Related by context. All words. (Click for frequent words.) 71 colorectal adenoma 69 postoperative AF 69 polyp recurrence 68 elevated ALT 67 thromboembolic 67 recurrent VTE 67 β blockers 66 perioperative mortality 66 recurrent venous thromboembolism 66 thrombocytopenic 66 thrombotic complications 66 thromboembolic events 66 atrophic gastritis 65 hemodialysis patients 65 beta blocker therapy 65 varices 65 hepatorenal syndrome 65 hemorrhagic complications 65 SHPT 65 antihypertensive therapy 65 advanced adenoma 65 postoperative atrial fibrillation 65 proliferative diabetic retinopathy 65 liver histology 65 GH deficiency 65 carotid stenosis 65 systolic hypertension 64 HIV HCV coinfected 64 serum phosphate 64 histologically confirmed 64 variceal bleeding 64 artery stenosis 64 nonvertebral fracture 64 TMP SMX 64 chronic periodontitis 64 T1DM 64 elevated serum creatinine 64 T2DM 64 post thrombotic syndrome 64 alanine aminotransferase ALT 64 oral anticoagulation 64 patients undergoing CABG 64 obstructive CAD 64 antibiotic prophylaxis 64 severe exacerbations 64 bacteriuria 64 thromboprophylaxis 64 esophageal varices 63 invasive aspergillosis 63 thromboembolism 63 CMV infection 63 FluCAM arm 63 LV dysfunction 63 ischemic cardiomyopathy 63 ADHF 63 perioperatively 63 NATRECOR R 63 prostate cancer CaP 63 D dimer 63 colorectal liver metastases 63 conventional angiography 63 renal scarring 63 isolated systolic hypertension 63 liver transplant recipients 63 heparin induced thrombocytopenia 63 upper gastrointestinal bleeding 63 distal colon cancer 63 nephrotoxicity 63 postoperative delirium 63 CP CPPS 63 atherogenic dyslipidemia 63 DVT PE 63 NAFLD 63 glomerular filtration 63 anemia hemoglobin 63 antithrombotic therapy 63 arterial thromboembolic events 63 invasive candidiasis 63 symptomatic VTE 63 primary aldosteronism 63 pretest probability 63 atherosclerotic disease 63 ximelagatran 63 NSTE ACS 63 paricalcitol 63 cirrhotic 63 serum lipid levels 63 venous thrombosis 63 intracranial hemorrhage ICH 62 total thyroidectomy 62 hematologic toxicity 62 elevated triglyceride levels 62 periprocedural 62 decompensated heart failure 62 adenoma recurrence 62 transferrin saturation 62 coronary stenosis 62 hyperkalemia 62 acute coronary syndromes ACS 62 recurrent DVT 62 prostate carcinoma 62 cranial irradiation 62 neurologic complications 62 pentoxifylline 62 aspartate aminotransferase AST 62 elevated LDL cholesterol 62 glycated hemoglobin levels 62 COPD exacerbation 62 thrombotic events 62 hyperglycaemia 62 hypertensives 62 liver resection 62 hypertensive patients 62 alteplase 62 left ventricular dysfunction 62 AST ALT 62 MULTAQ 62 postoperative morbidity 62 corticosteroid dose 62 homocysteine concentrations 62 renal impairment 62 albumin excretion rate 62 hepatocellular carcinomas 62 postoperative infections 62 aortic valve stenosis 62 thromboembolic complications 62 corticosteroid therapy 62 Erythropoietic therapies may 62 systemic corticosteroids 62 stable angina 62 HGPIN 62 diabetes mellitus DM 62 locoregional recurrence 62 CRBSI 62 renal insufficiency 62 MACCE 62 hepatotoxicity 62 HbA 1c levels 62 locoregional 62 antireflux surgery 62 UPPP 62 octreotide LAR 62 venous thromboembolic disease 62 Asymptomatic 62 secondary hyperparathyroidism 62 SCIg 62 NNT = 62 serum GGT 62 ß blockers 62 intravenous diuretics 62 Venous thromboembolism 62 hepatic cirrhosis 62 recurrent atrial fibrillation 62 microvascular complications 62 carotid surgery 62 riociguat 62 nonvertebral fractures 62 hypercalcemia 62 COPD exacerbations 61 pericardial effusion 61 intravesical therapy 61 postoperative mortality 61 chronic rhinosinusitis 61 microalbuminuria 61 perioperative complications 61 rebleeding 61 carotid artery stenting CAS 61 candidemia 61 PHPT 61 prolonged QT interval 61 preoperative chemotherapy 61 aldosterone antagonists 61 acromegalic patients 61 evaluable subjects 61 NMIBC 61 systolic dysfunction 61 perioperative morbidity 61 pyridostigmine 61 urolithiasis 61 PSADT 61 CMV disease 61 acute humoral rejection 61 Thrombolysis 61 advanced adenomas 61 severe renal impairment 61 contrast induced nephropathy 61 HeFH 61 antimicrobial prophylaxis 61 CIN3 61 overt nephropathy 61 carotid IMT 61 histological subtype 61 antiarrhythmic drugs 61 nondiabetic patients 61 lipid lowering therapy 61 cinacalcet 61 curative resection 61 stage IIIB 61 gastric varices 61 BENICAR HCT 61 rFVIIa 61 p = #.# [003] 61 pT3 61 anastomotic leak 61 serum urate levels 61 platelet reactivity 61 cardiac troponin T 61 symptomatic DVT 61 inotropic 61 intracerebral hemorrhage 61 hyperoxaluria 61 transaminase levels 61 mucosal healing 61 reflux symptoms 61 diabetic gastroparesis 61 thromboembolic disease 61 metastatic RCC 61 myopathy rhabdomyolysis 61 VTE prophylaxis 61 NIH CPSI 61 hypercalciuria 61 gastroduodenal 61 VTEs 61 stratifying patients 61 subclinical atherosclerosis 61 intrahepatic 61 elevated homocysteine 61 intravascular hemolysis 61 subclinical hypothyroidism 61 APTIVUS r 61 recurrent UTI 61 venous thromboembolism 61 bronchial hyperresponsiveness 61 serum sodium 61 elevated uric acid 61 elevated LDH 61 dysglycemia 61 androgen deprivation 61 hypercholesterolaemia 61 CTEPH 61 hepatic fibrosis 61 oral prednisolone 61 carotid endarterectomy CEA 61 symptomatic intracranial hemorrhage 61 serum calcium 60 atherothrombotic disease 60 recurrent myocardial infarction 60 abdominal adiposity 60 pelvic lymphadenectomy 60 transaminase elevations 60 HBeAg negative 60 ACEIs 60 knee osteoarthritis OA 60 metabolic acidosis 60 tumor lysis syndrome 60 specific antigen PSA 60 malignant neoplasm 60 nonalcoholic steatohepatitis NASH 60 de novo AML 60 serum phosphorous 60 INVEGA ® 60 antithrombotic agents 60 graft occlusion 60 hemoglobin A1c levels 60 pulmonary dysfunction 60 elevated troponin 60 morbidity mortality 60 carotid artery stenosis 60 metformin monotherapy 60 chronic GVHD 60 gallstone disease 60 endometrial hyperplasia 60 hepatocellular 60 nonmelanoma skin cancers 60 untreated celiac disease 60 serum PSA 60 carcinoid tumors 60 aminotransferase ALT 60 elevated CRP 60 troponin T 60 revascularization procedures 60 urothelial cancer 60 elevated creatinine 60 Mitomycin C 60 reperfusion therapy 60 hemodilution 60 reinfarction 60 mixed hyperlipidemia 60 HNSCC 60 gastric adenocarcinoma 60 cobiprostone 60 SGPT 60 urothelial carcinoma 60 DAPT 60 hypoglycemic episodes 60 femoral neck fracture 60 Aspergillus infections 60 nocturnal hypoglycaemia 60 elevated IOP 60 serum ALT 60 hydroxyvitamin D levels 60 infective endocarditis 60 hypoxemia 60 resectable 60 variceal hemorrhage 60 pulmonary capillary wedge 60 macroalbuminuria 60 platelet inhibition 60 Liver transplantation 60 clevidipine 60 PsA 60 renal tumors 60 myocardial reperfusion 60 venous thromboembolisms 60 reinterventions 60 postoperative complication 60 revascularisation 60 antiarrhythmic drug 60 KRAS mutant tumors 60 umol L 60 CsA 60 adrenalectomy 60 IPAH 60 idraparinux 60 hematopoietic cancers 60 KRAS mutations occur 60 plasma folate 60 hyperbilirubinemia 60 fructose intolerance 60 NATRECOR ® 60 PREZISTA r 60 cerebral vasospasm 60 prostate cancer PCa 60 cytoreductive nephrectomy 60 platelet activation 60 OSAHS 60 hyperphenylalaninemia HPA due 60 thoracoscopic lobectomy 60 serum potassium 60 neutropaenia 60 grade cervical intraepithelial 60 nonalcoholic steatohepatitis 60 HBeAg seroconversion 60 venous thromboembolic 60 anterior uveitis 60 esophagogastric 60 relapsed MM 60 alanine aminotransferase 60 chronic thromboembolic pulmonary 60 CYPHER Stent 60 MetS 60 prolongs survival 60 PSA nadir 60 hemorrhagic cystitis 60 ARIXTRA 60 lipid elevations 60 venous blood clots 60 mycophenolate mofetil 60 benazepril 60 coronary calcification 60 antiplatelet medication 60 fibrinolysis 60 recurrent ischemia 60 diastolic hypertension 60 ertapenem 60 recurrent glioblastoma multiforme 60 aminotransferases 60 NYHA functional class 60 detrusor overactivity 60 postoperative infection 60 VT VF 60 nonischemic 60 PCa 60 inotropes 60 thromboses 60 macrovascular disease 60 erythropoietic 60 aspartate aminotransferase 60 serum ferritin 60 LAGB 60 rt PA 60 angiographically 60 chronic hepatitis cirrhosis 60 bicuspid aortic valves 60 subtrochanteric 60 hepatic insufficiency 60 lung resection 60 transrectal ultrasound guided 60 leukocyte count 60 FOLFOX4 60 trials RCTs 60 postoperative pulmonary 60 salmeterol fluticasone propionate 60 methotrexate monotherapy 60 left ventricular systolic 60 plasma pharmacokinetics 60 neutrophil counts 60 serum cortisol 60 cytoreductive surgery 60 percutaneous vertebroplasty 60 biochemical relapse 60 MMSE scores 60 serum phosphate levels 60 occlusive disease 60 nodal metastasis 60 ventricular remodeling 60 lipid parameters 59 macrovascular events 59 CIN2 + 59 virological response 59 atorvastatin #mg 59 atherothrombotic events 59 deep venous thromboses 59 ICD implantation 59 urinary symptoms 59 onset diabetes mellitus 59 interstitial pneumonia 59 Adjuvant chemotherapy 59 direct thrombin inhibitors 59 atherothrombotic 59 dose statin therapy 59 undergoing coronary angiography 59 Calcium intake 59 hypervolemic 59 System IPSS 59 probiotic supplementation 59 glycosylated hemoglobin HbA1c 59 GP IIb IIIa inhibitors 59 renal dysfunction 59 inflammatory biomarkers 59 mycophenolate mofetil MMF 59 AA Amyloidosis 59 coronary intervention 59 peptide BNP 59 radioiodine therapy 59 alcoholic fatty liver 59 carotid artery stenting 59 serum calcium levels 59 fructose intolerant 59 underwent coronary angiography 59 NSTEMI 59 carotid angioplasty 59 empyema 59 chemoradiotherapy 59 colorectal neoplasms 59 Hepatocellular Carcinoma HCC 59 bronchogenic carcinoma 59 fragility fracture 59 CrCl 59 nicardipine 59 vertebral fracture 59 HBeAg 59 gastric cardia 59 juvenile idiopathic arthritis 59 HSCT 59 intact parathyroid hormone 59 oral anticoagulant therapy 59 adjuvant radiotherapy 59 mitochondrial toxicity 59 prospective multicenter study 59 solifenacin 59 pulmonary hypertension PH 59 leucopenia 59 eosinophilic asthma 59 histologic subtype 59 glycoprotein IIb IIIa inhibitors 59 Hb A1C 59 morphometric vertebral fractures 59 H. pylori infection 59 coronary artery calcification 59 ABCB1 59 dose atorvastatin 59 diabetic kidney 59 pCR 59 fasting triglyceride levels 59 depressive symptomatology 59 alfuzosin 59 malignant pleural mesothelioma 59 intermittent claudication 59 periprocedural MI 59 colectomy 59 serum aminotransferase levels 59 patients undergoing percutaneous 59 salmeterol fluticasone 59 parathyroidectomy 59 hypervolemic hyponatremia 59 comorbid depression 59 recurrent wheezing 59 hyperresponsiveness 59 aortic atherosclerosis 59 IV NSCLC 59 undergoing radical prostatectomy 59 symptomatic BPH 59 recurrent miscarriage 59 invasive fungal infection 59 hepatic metastases 59 mRCC 59 metachronous 59 nonsevere 59 tissue oxygenation 59 % CI #.#-#.# [008] 59 OAB symptoms 59 carotid atherosclerosis 59 abnormal lipids 59 H. pylori eradication 59 tirofiban 59 cervical intraepithelial neoplasia 59 esophagitis 59 hepatic function 59 unstable angina UA 59 SGRQ 59 TT genotype 59 autonomic dysfunction 59 tipranavir r 59 QTc interval 59 acetabular dysplasia 59 unstable angina pectoris 59 Critical Limb Ischemia CLI 59 pathologic fractures 59 symptomatic intracranial 59 EXJADE 59 bacterial prostatitis 59 gastric carcinoma 59 hypophosphatemia 59 binary restenosis 59 myocardial ischemia 59 lipid abnormalities 59 Radical prostatectomy 59 surgical revascularization 59 concomitant medications 59 % CI #.#-#.# [007] 59 idiopathic PAH 59 preoperative PSA 59 EDSS scores 59 functional mitral regurgitation 59 incomplete revascularization 59 coronary artery calcium 59 chronic renal insufficiency 59 serum uric acid 59 tolvaptan 59 TAXUS Express Stent 59 PRADAXA 59 BYSTOLIC 59 cytoreduction 59 TNF antagonist 59 SERCA2a 59 symptomatic fibroids 59 glycemia 59 postoperative radiotherapy 59 HoFH 59 kidney allograft 59 hyperammonemia 59 thiazide diuretic 59 oral FTY# 59 gastrointestinal perforation 59 inflammatory polyarthritis 59 RAS mutations 59 STRIDE PD 59 oral Hycamtin 59 gross hematuria 59 angiotensin II receptor blockers 59 neoadjuvant 59 oral antidiabetic medication 59 noncardiac 59 angina chest 59 epithelial ovarian cancer 59 lactate dehydrogenase 59 ketorolac 59 dyslipidaemia 59 androgen suppression 59 colorectal neoplasia 59 canakinumab 59 thiazide diuretics 59 malignant neoplasms 59 anticoagulation therapy 59 psoriatic arthritis PsA 59 adenomatous 59 VTE 59 asymptomatic carotid stenosis 59 esophageal squamous cell carcinoma 59 acute GVHD 59 amenorrhoea 59 refractory ischemia 59 sUA 59 VAPRISOL 59 mitral regurgitation 59 euvolemic 59 generalized seizures 59 POAG 59 Vitamin D insufficiency 59 antidiabetic drugs 59 nonoperative 59 PPCM 59 papillary renal cell carcinoma 59 hypoglycaemic episodes 59 pulmonary artery banding 59 fetal chromosomal 59 antiplatelet medications 59 underwent angiography 59 lipid lowering drugs 59 biochemical recurrence 59 polytherapy 59 MADRS score 59 CK MB 59 multivessel disease 59 postoperative complications 59 Ishak fibrosis score 59 Fluid retention 59 cilostazol 59 urinary albumin excretion 59 Legg Calvé Perthes disease 59 extrapyramidal symptoms 59 torsade de pointes 59 pyelonephritis 59 portal vein thrombosis 59 adenomatous polyps 59 adenoma 59 haemorrhagic stroke 59 haematologic 59 thrombocytopenic patients 59 simvastatin ezetimibe 59 cardiopulmonary bypass CPB 59 mitral stenosis 59 antithrombotics 59 serum urate 58 cardioembolic stroke 58 Prehypertension 58 mIU L 58 hypercholesterolemic patients 58 ACTEMRA TM 58 basal cell nevus syndrome 58 stenting procedures 58 angioplasty stenting 58 ACE Inhibitors 58 untreated OSA 58 nonmetastatic prostate cancer 58 HBeAg negative patients 58 baseline LDH 58 completely resected 58 abnormal cytology 58 renal function 58 plasma creatinine 58 coadministration 58 Hypotension 58 NIASPAN 58 acute aortic dissection 58 coronary revascularization 58 Chronic Heart Failure 58 primary hyperparathyroidism 58 chronic prostatitis 58 bezafibrate 58 curative therapy 58 undergone radical prostatectomy 58 receiving highly emetogenic 58 SRBD 58 colorectal carcinoma 58 tuberculin skin testing 58 coronary blockages 58 virologic failure 58 fluticasone salmeterol 58 nonoperative treatment 58 serum testosterone 58 external genital lesions 58 NSAID therapy 58 % CI #.#-#.# [003] 58 osteoporotic vertebral compression fractures 58 radical nephrectomy 58 serum parathyroid hormone 58 aspirin clopidogrel 58 BLLs 58 teriflunomide 58 salmeterol HFA MDI 58 IFN beta 58 unfavorable cytogenetics 58 interferon ribavirin 58 nonadherence 58 acute urinary retention 58 gestational hypertension 58 symptomatic carotid stenosis 58 Toxicities 58 reactogenicity 58 ventricular arrhythmia 58 prednisone prednisolone 58 nephrolithiasis 58 UA NSTEMI 58 thyrotropin levels 58 cerebrovascular events 58 severe neutropenia 58 PAOD 58 Proteinuria 58 RRMS patients 58 ASCUS 58 RYGB 58 prognostic variables 58 lomitapide 58 myeloperoxidase 58 hepatectomy 58 systolic function 58 eplerenone 58 cutaneous melanoma 58 genital herpes infections 58 leiomyomas 58 squamous cell lung cancer 58 hepatic impairment 58 microvascular disease 58 preserved ejection fraction 58 thrombolytic agents 58 postexposure prophylaxis 58 fluvastatin 58 anticoagulated 58 hepatocellular carcinoma 58 intensive statin therapy 58 GnRH agonists 58 Postoperatively 58 S. aureus isolates 58 sulphonylureas 58 peritumoral brain edema 58 CTAP# Capsules 58 IOP lowering 58 XIENCE V PROMUS Stent 58 fondaparinux 58 acute myocardial infarction MI 58 subclinical hyperthyroidism 58 variceal 58 biliary tract cancer 58 Kinoid 58 ALT elevations 58 silent ischemia 58 aldosterone antagonist 58 restenosis reblockage 58 severe aortic stenosis 58 pneumonectomy 58 sirolimus eluting stents 58 Acute Coronary Syndromes ACS 58 intracranial hypertension 58 acute GvHD 58 clinically localized prostate 58 improves glycemic 58 oesophageal adenocarcinoma 58 Captopril 58 alemtuzumab treated 58 thyrotoxicosis 58 irbesartan 58 liposomal amphotericin B 58 loop diuretics 58 HES CEL 58 albuminuria 58 salivary flow 58 claudication 58 vesicoureteral reflux 58 HMG CoA reductase inhibitors 58 hsCRP levels 58 urate levels 58 ATACAND 58 graft dysfunction 58 EpCAM expression 58 ancrod 58 ventricular tachyarrhythmia 58 pheochromocytoma 58 cardiac dysfunction 58 baseline HbA1c 58 HbA 1c 58 achieved ACR# 58 HER2 expression 58 ovarian carcinoma 58 Subgroup analyzes 58 dalteparin 58 cisplatin chemotherapy 58 Exacerbations 58 pulmonary artery catheterization 58 renal artery stenting 58 chronic idiopathic thrombocytopenic purpura 58 cerebral perfusion 58 plasma uric acid 58 nonfatal MI 58 biliary stones 58 euvolemic hyponatremia 58 LTBI 58 candesartan 58 Ophena TM 58 minimally symptomatic 58 coronary artery stenosis 58 ALI ARDS 58 preserved LVEF 58 extracolonic findings 58 membranous nephropathy 58 coinfected patients 58 Non Alcoholic Fatty 58 serum glucose 58 Barrett esophagus BE 58 serum LDL cholesterol 58 lipid lowering therapies 58 CVD mortality 58 heterozygous FH 58 LNG IUS 58 prospectively evaluated 58 K DOQI 58 #OHD 58 aromatase inhibitors AIs 58 thiazides 58 TEAEs 58 iPTH 58 atherosclerotic renal artery stenosis 58 aortic root replacement 58 Hip fracture 58 posttransplant 58 virological failure 58 angiotensin converting enzyme inhibitors 58 STEMI patients 58 HBeAg positive 58 Adenomas 58 symptomatic aortic stenosis 58 titrated glipizide 58 hyperparathyroidism 58 latent tuberculosis infection 58 CDI recurrence 58 metastatic GIST 58 intravenous thrombolysis 58 gadobutrol 58 complete cytogenetic response 58 Infusion Reactions Severe 58 histologically proven 58 gastric cancers 58 invasive fungal infections 58 serum creatinine levels 58 BMPR2 58 ventricular tachycardia VT 58 undergoing CABG 58 advanced neoplasia 58 overt hypothyroidism 58 neurodevelopmental impairment 58 KRAS status 58 EBRT 58 Aortic stenosis 58 paroxysmal AF 58 pulmonary exacerbation 58 serum estradiol 58 Lung transplantation 58 arteriography 58 lowering blood glucose 58 hyperphosphatemia 58 ADPKD 58 esophagectomy 58 underwent resection 58 HbA1c levels 58 TACE 58 HPA axis suppression 58 PASI scores 58 steatohepatitis 58 neurocognitive function 58 dosing frequency 58 Adalimumab 58 #.#ng/ml 58 hypotensive 58 chlamydial infection 58 antihypertensive medications 58 smoldering multiple myeloma 58 nephron sparing surgery 58 acute coronary syndrome 58 carotid artery narrowing 58 glucocorticoid therapy 58 IV bisphosphonates 58 severe hypoglycemia 58 immunosuppressive regimen 58 Postoperative complications 58 anticonvulsant medications 58 precursor lesions 58 CIMZIA ™ 58 anti JCV antibodies 58 tenecteplase 58 H pylori 58 spontaneous preterm delivery 58 LEXIVA r 58 esophageal cancers 58 carotid plaque 58 carotid plaques 58 thyrotropin 58 rapid virological response 58 cervical carcinoma 58 IL 1ß 58 deferiprone 58 metastatic neuroendocrine tumors 58 somatostatin analogs 58 pulmonary toxicity 58 adenotonsillectomy 58 cardiotoxicity 58 serum PTH 58 lactic acidosis 58 mcg BID 58 prescribed statins 58 induce remission 58 atherothrombosis 57 elevated triglycerides 57 doxorubicin docetaxel 57 International Prognostic Scoring 57 serum homocysteine 57 anticholinergic medication 57 hepatocellular cancer 57 glomerular filtration rate 57 acute coronary syndromes 57 cerebrovascular accidents 57 Natalizumab 57 inducible ischemia 57 bolus dose 57 epithelial tumors 57 ALND 57 Y BOCS 57 crossclamp 57 serum thyroglobulin 57 adult chronic ITP 57 carotid endarterectomy 57 LVSD 57 symptomatic paroxysmal AF 57 perimenopausal women 57 Severe hypoglycemia 57 mepolizumab 57 Lp PLA 2 57 cTnT 57 wound dehiscence 57 receiving immunosuppressive therapy 57 Combination therapy 57 embolic stroke 57 posaconazole 57 treated nonsurgically 57 serum vitamin D 57 angiotensin receptor blockers 57 preintervention 57 bacteraemia 57 catheter angiography 57 Coronary Artery Bypass Graft 57 latent celiac disease 57 postoperative chemotherapy 57 relapsed SCLC 57 immunosuppression therapy 57 grade cervical dysplasia 57 idiopathic myelofibrosis 57 macrovascular 57 acid suppressive therapy 57 renal toxicity 57 bypass graft CABG surgery 57 valvulopathy 57 Subgroup analysis 57 LVNC 57 colorectal cancer CRC 57 hepatic steatosis 57 spirometric 57 dosage regimens 57 SSc 57 autoimmune thyroid 57 rosuvastatin #mg 57 lumbar disk herniation 57 contrast echocardiography 57 receiving VICTRELIS 57 hepatic dysfunction 57 SHBG levels 57 oncologic outcomes 57 mL/min/#.# m 2 57 sotalol 57 antiemetics 57 endometrial carcinoma 57 debulking surgery 57 Subarachnoid hemorrhage 57 impaired renal 57 atherosclerotic lesions 57 oral corticosteroids 57 timepoint 57 calcified plaques 57 pT2 57 pouchitis 57 Contrast Induced Nephropathy CIN 57 Doxil ® 57 carotid artery blockage 57 HER2 overexpression 57 antigen PSA levels 57 posttreatment 57 grade glioma 57 AUDs 57 hemoglobin A1c HbA1c 57 normotensive 57 hypocalcemia 57 colorectal bowel 57 β blocker 57 distal embolization 57 lopinavir r arm 57 intravenous bisphosphonates 57 platelet inhibitor 57 cerebral infarction 57 serum sodium levels 57 Catheter ablation 57 lactate dehydrogenase LDH 57 H2 antagonists 57 hepatic enzymes 57 familial hypercholesterolemia 57 N telopeptide 57 vasopressor 57 mmHg diastolic 57 F FDG PET 57 clinically asymptomatic 57 distant metastases